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AbstrACt
Introduction Pre- diabetes is a high- risk state for the 
development of type 2 diabetes mellitus (T2DM) and 
cardiovascular disease. Regression to normoglycaemia, 
even if transient, significantly reduces the risk of 
developing T2DM. The primary aim of this mixed- methods 
study is to determine if there are clinically relevant 
differences among those with pre- diabetes and excess 
weight who regress to normoglycaemia, those who have 
persistent pre- diabetes and those who progress to T2DM 
following participation in a 6- month primary care nurse- 
delivered pre- diabetes dietary intervention. Incidence of 
T2DM at 2 years will be examined.
Methods and analysis Four hundred participants 
with pre- diabetes (New Zealand definition glycated 
haemoglobin 41–49 mmol/mol) and a body mass index 
>25 kg/m2 will be recruited through eight primary care 
practices in Hawke’s Bay, New Zealand. Trained primary 
care nurses will deliver a 6- month structured dietary 
intervention, followed by quarterly reviews for 18 months 
post- intervention. Clinical data, data on lifestyle factors 
and health- related quality of life (HR- QoL) and blood 
samples will be collected at baseline, 6 months, 12 
months and 24 months. Sixty participants purposefully 
selected will complete a semi- structured interview 
following the 6- month intervention. Poisson regression 
with robust standard errors and clustered by practice will 
be used to identify predictors of regression or progression 
at 6 months, and risk factors for developing T2DM at 
2 years. Qualitative data will be analysed thematically. 
Changes in HR- QoL will be described and potential cost 
savings will be estimated from a funder’s perspective at 2 
years.
Ethics and dissemination This study was approved by 
the Northern A Health and Disability Ethics Committee, 
New Zealand (Ethics Reference: 17/NTA/24). Study 
results will be presented to participants, published 
in peer- reviewed journals and presented at relevant 
conferences.
trial registration number ACTRN12617000591358; 
Pre- results.
IntroduCtIon
The prevalence of diabetes and concomi-
tant costs continue to increase.1–4 Diabetes 
now affects an estimated 8.8% of adults 
globally.5 Pre- diabetes, a condition in which 
blood glucose levels are higher than normal, 
but not high enough to be classified as 
diabetes, is more common, affecting as many 
as 30%–50% of some adult populations.6–9 
Without treatment, about 5%–10% of those 
with pre- diabetes will progress to type 2 
diabetes mellitus (T2DM) annually, and most 
will eventually develop T2DM.10 11 Lifestyle 
modification and weight loss can prevent or 
delay progression,12–18 with the overall risk 
being approximately halved.19 Medication 
strengths and limitations of this study
 ► This mixed- methods study follows a pragmatic non- 
randomised pilot study which showed that a primary 
care nurse- delivered 6- month dietary intervention 
for people with pre- diabetes and body mass index 
>25 kg/m2 was feasible in a primary care setting, 
and weight loss was achieved in the intervention 
group.
 ► The study is set in a geographical region where 
approximately 21% of the population is Māori, the 
indigenous peoples of New Zealand, who have high 
rates of pre- diabetes and type 2 diabetes mellitus.
 ► Following the 6- month dietary intervention, partic-
ipants will be reviewed every 3 months by primary 
care nurses for 18 months.
 ► A possible limitation is that the study is taking place 
in a real- world setting, and health sector changes 
influencing the primary care environment may influ-
ence the study outcomes.
 ► This study is limited as it will not include a control 
group.
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has also been shown to prevent T2DM in people with pre- 
diabetes enrolled in clinical trials.12 19–21
Implementing diabetes prevention lifestyle interventions in 
primary care: the challenges
Implementing diabetes prevention lifestyle clinical trial 
evidence into real- world settings is challenging, partic-
ularly in primary care settings,22–24 where those with 
pre- diabetes are typically a more heterogeneous group 
compared with those participating in clinical trials.25 
Further, the cost of delivering lifestyle interventions in 
primary care can be a barrier.26 The Diabetes Preven-
tion Program (DPP) lifestyle intervention costs US$1399 
per participant in the first year.27 A significant propor-
tion of this cost was specialist lifestyle intervention staff, 
who are often employed in diabetes prevention lifestyle 
programmes, irrespective of the setting.12–17 28–35 Few 
studies have specifically employed primary care nurses to 
deliver lifestyle advice,36–39 although dietary advice given 
by an appropriately trained nurse can be as effective as 
that given by a dietitian in the primary care setting,38 and 
is potentially more sustainable and cost- effective.40
Furthermore, as pre- diabetes increases the risk of not 
only T2DM, but also cardiovascular disease,6 11 41 and the 
microvascular complications associated with diabetes,6 42 
the goal of pre- diabetes screening and treatment should 
arguably be regression to normoglycaemia.11 21 43 Even 
if transient, regression to normoglycaemia is associated 
with a significantly reduced risk of developing T2DM, 
independent of whether this occurs spontaneously or 
in response to lifestyle advice or metformin therapy.44 
Greater insulin secretion, lower baseline glucose concen-
trations, younger age, weight loss and intensive lifestyle 
modification predict restoration of normoglycaemia,45–47 
but other factors such as sociocultural, economic and 
health service delivery, which have not been previously 
examined, may also be important.
Pre-diabetes lifestyle interventions have been implemented in 
primary care
The primary care- based Pre- diabetes Intervention Package 
(PIP) is a feasible primary care nurse- delivered 6- month 
pre- diabetes lifestyle intervention with a focus on diet, 
sociocultural context and goal setting, for overweight 
and obese patients with pre- diabetes.48 In this pragmatic 
mixed- methods non- randomised pilot study conducted in 
the Hawke’s Bay region, New Zealand (NZ), intervention 
implementation fidelity was high and after adjustment, 
the intervention group lost a mean 1.3 kg more than the 
control group (p<0.0.001). The mean glycated haemo-
globin (HbA1c) decreased in the intervention group 
and increased in the control group, but the difference 
was not significantly different. Extending the study and 
offering the intervention to all study practices, alongside 
exploring clinical, as well as sociocultural, economic and 
genetic variables, provides an opportunity to determine if 
there are clinically relevant differences among those with 
pre- diabetes who regress to normoglycaemia, who have 
persistent pre- diabetes and who progress to T2DM. It is 
anticipated that these prospectively collected data will 
contribute to limited international data on sociocultural 
factors that may be associated with regression from pre- 
diabetes to normoglycaemia,45 and to clinical decision- 
making risk assessments in the primary care setting.21 49
The primary aim of this study is (1) to determine if 
there are clinically relevant differences among those with 
pre- diabetes who regress to normoglycaemia, those who 
have persistent pre- diabetes and those who progress to 
T2DM at 6 months following participation in a structured 
primary care nurse- delivered pre- diabetes dietary inter-
vention in the primary care setting. The secondary aims 
are (2) to quantify the reduction in incident T2DM at 
2 years in participants who regressed to normoglycaemia 
at 6 months compared with the other participants; (3) to 
qualitatively explore and examine barriers, challenges 
and facilitators of clinically meaningful lifestyle changes 
between those who regress to normoglycaemia and those 
who do not; (4) to explore whether a T2DM genetic risk 
score of common genetic variants might influence regres-
sion to normoglycaemia at 2 years in a sub- sample, (5) to 
describe changes in HR- QoL at 2 years and (6) to esti-
mate the potential cost savings to the health sector associ-
ated with a reduction in T2DM.
MEthods And AnAlysIs
This extension of the PIP pilot study is a mixed- method 
prospective cohort study with pre- intervention and post- 
intervention measures and a qualitative study.50 51
nZ context
In NZ, among adults aged 15 years and over, the prevalence 
of diabetes is 7.0% and the prevalence of pre- diabetes is 
25.5%.7 Māori, the indigenous people of NZ, and Pacific 
people have higher rates than the NZ European and 
Other ethnic group, with diabetes rates of 9.8%, 15.4% 
and 6.1%, respectively, and pre- diabetes rates of 30.4%, 
29.8% and 24.6%, respectively.7 Screening for diabetes 
and pre- diabetes is recommended as part of cardiovas-
cular risk assessment.52 For those with no symptoms and 
no known risk factors, screening is recommended from 
45 years for men and 55 years for women, with Māori, 
Pacific, Indo- Asian peoples, and those with known cardio-
vascular risk factors or at high risk of developing diabetes 
to be screened 10 years earlier, or even younger if there is 
particular clinical concern regarding unfavourable risk 
factors.52
study setting
The study will be conducted in general practices in the 
urban zones of two neighbouring provincial cities (Napier 
and Hastings) in the Hawke’s Bay region, NZ. Napier 
had a population of 57 240 (18.2% Māori) and Hast-
ings District had a population of 73 245 (23.0% Māori) 
in 2013.53 Māori comprise 15% of the NZ population.54 
The general practices will be members of the Health 
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Hawke’s Bay Primary Health Organisation (PHO). PHOs 
are not- for- profit organisations that provide primary 
health services either directly or through their provider 
members. Health Hawke’s Bay is the only PHO in the 
study region.
Patient and public involvement
The PIP was designed in collaboration with the Health 
Hawke’s Bay PHO.48 The intervention was first pre- tested 
with members of the public, then primary care nurses 
reviewed and contributed to the implementation and 
research protocols at a meeting. The process evaluation 
by an independent researcher48 enabled views about the 
intervention and its implementation from patient partici-
pants, participating nurses and Health Hawke’s Bay PHO 
staff involved in the design and implementation to be 
incorporated into the planning of this study. Results of 
the pilot study and process evaluation were presented and 
discussed at a forum to which all participants (patients 
and professionals) were invited.
Participant eligibility
General practices who use the Medtech patient manage-
ment system and employ primary care nurses will 
be invited to participate in the study. The reason for 
including general practices using Medtech is that this is 
the dominant patient management system in Hawke’s 
Bay, and study data collection systems had been modified 
for Medtech only in the pilot study. The demographic 
description of practice populations will be reviewed to 
ensure that patients with different sociocultural back-
grounds are offered the opportunity to participate.
Adults aged 18–69 years with pre- diabetes (defined as 
HbA1c 41–49 mmol/mol according to the NZ diagnostic 
criteria)52 and a body mass index (BMI) ≥25 kg/m2 will be 
included. Pre- diabetes will have been diagnosed following 
screening (at the time of a recommended cardiovas-
cular risk assessment or because they are deemed to be 
at risk).52 We set a lower age limit of 18 years to reflect 
the high prevalence of pre- diabetes in young adults in 
NZ, particularly in high- risk ethnic groups including 
indigenous Māori and Pacific.7 Those with a history of 
diabetes, prescribed metformin, unable to communicate 
in English, with a terminal illness or planning to move 
from the area during the first 6 months of the study and 
women pregnant at the time of study enrolment will be 
excluded.
Identification of potential participants and recruitment
General practice patient management systems will be used 
to identify potential eligible participants. Queries will be 
conducted using the HbA1c, BMI, age and metformin 
status criteria to generate lists of potential participants. 
The queries will not be time- constricted. Primary care 
nurses will review these lists to check eligibility status 
including co- morbidities, current medications, confirma-
tion of English- speaking ability and pregnancy status. The 
lists will be generated in no particular order.
Potential participants will be recruited sequentially 
according to the random lists generated, in order to 
minimise selection bias. The research nurse will check 
these lists regularly to assess who has been invited, who 
has declined and who is yet to be invited. A letter inviting 
participation and information about the study will be 
sent to potential participants in blocks to manage nurse’s 
workload. Potential participants will be contacted by their 
primary care nurse 5–7 days later to determine partici-
pation status and to make a baseline study appointment 
for those choosing to participate. For those who decline 
to participate, the nurse will record the reason(s). Those 
diagnosed with pre- diabetes after recruitment begins and 
those who meet the eligibility criteria will be invited to 
participate at the time of their diagnosis.
Intervention
The intervention will be delivered by trained primary 
care nurses in the general practice setting. The key 
underpinning principle of the intervention is to provide 
participants (and their family) with an understanding of 
the principles of healthy eating and to deliver consistent 
evidence- based dietary messages, so they are empowered 
to make good dietary choices; that is, the dietary advice 
will not be prescriptive. This pragmatic intervention 
package has six components48:
Health Professional Training and Support
Primary care nurses will undertake an intensive 3–4 hour 
theoretical and practical training course. The course 
content will include the rationale for the study, key nutri-
tional concepts, dietary assessment in the primary care 
setting (using Starting the Conversation (STC)55 modi-
fied for the NZ context),48 healthy conversations and goal 
setting. The nurses will be instructed how to use the PIP 
study- structured dietary tool,48 and about the necessary 
research processes (informed consent and data collec-
tion). They will also be instructed on standard practices 
for measuring anthropometry and blood pressure. The 
course will be delivered by study investigators and a local 
dietitian. A training manual will provide reference mate-
rial for both primary care nurses and participants, as well 
as research protocols. A half- day update course will be 
run at 6 months.
The local dietitian will be available by email and phone 
to answer any queries or discuss specific clinical cases. The 
dietitian will also arrange monthly clinical case review 
meetings for 6 months at each practice. Both the primary 
care nurses and dietitian found that dietitian’s support 
and guidance was only required for up to 6 months in the 
pilot study.48 A research nurse will also visit participating 
practices to provide support and advice, as needed, to 
maximise intervention fidelity.
Individualised dietary assessment, goal setting and dietary advice 
sessions
The intervention goal is a 10% wt loss over 6 months. 
After providing informed written consent, participants 
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will be offered an initial 30 min individualised dietary 
session with their primary care nurse. They will be encour-
aged to bring family to the session. A brief structured 
dietary assessment will be undertaken. STC:Diet, a vali-
dated eight- item simplified food frequency instrument 
designed for use in primary care and health- promotion 
settings, will be used.55 STC:Diet was minimally modified, 
with permission, for the NZ context. Specifically, the 
word ‘sodas’ was changed to ‘soft drinks’, and a traffic 
light system was added to indicate healthy, not- so healthy 
and unhealthy dietary habits. The nurse will review the 
STC:Diet responses; ask additional dietary prompt ques-
tions; seek additional contextual information, such as 
household membership and budget, who purchases 
household foods and specific dietary requirements/
choices such as vegetarianism and take anthropometric 
measures (height, weight and waist circumference) using 
calibrated equipment. The additional questions are 
called the Detailed Dietary Assessment (DDA). A 10% wt 
loss goal over 6 months will be calculated. Responses to 
the STC:Diet and DDA will inform three dietary goals 
negotiated with the participant, and individualised 
dietary advice. Participants will be given the standard 
‘Be Active Every Day’ pamphlet, which advises 30 min 
of physical activity of moderate intensity on most, if not 
all, days of the week.56 Follow- up intervention appoint-
ments will be arranged at 2–3 weeks, 6 weeks, 3 months, 
4 months and 6 months, then 3- monthly appointments 
for a ‘weigh- in’ and provision of ongoing brief targeted 
dietary advice and support for 18 months. Intervention 
appointments at 6 weeks and 4 months were added, 
following feedback from both participants and nurses in 
the feasibility study.48 All study appointments will be at 
no cost to the participant.
Key messages and consistent opportunistic reminders
Each participant’s three dietary goals will be recorded in 
the practice patient management system. These goals and 
accompanying clinical notes will facilitate opportunistic 
targeted advice and guidance by GPs, thus reinforcing 
dietary advice and support provided by the nurses. 
The goals will be reviewed and updated accordingly at 
follow- up nurse appointments.
Nutritionally supportive primary care environment
Prior to the beginning of this study, each interven-
tion practice will be visited to discuss ways to enhance 
dietary messages provided by nurses. Specifically, the 
dietary information provided in pamphlets, magazines 
and posters in the waiting rooms will be reviewed and 
updated, if necessary, so dietary messages are appropriate 
and consistent. Provision of magazines that support repu-
table dietary messages and active living, hobbies and 
sports and posters promoting fruit and vegetables, such 
as those offered by  Vegetables. co. nz ( www. vegetables. co. 
nz), will be encouraged.
Community-based group education for participants and their family
At the 2–3 week intervention appointment, nurses will 
refer participants to the Kia Ora programme, a commu-
nity group nutrition education course consisting of 
six weekly sessions of 2.5 hours. The Kia Ora programme 
is an approved Stanford chronic disease self- management 
programme.57 58 The education sessions will be delivered 
by lay trainers, and topics will include healthy eating, 
label reading, problem solving and making action plans.
Written patient resources
Readily available patient resources will be utilised. The 
key resource will be the Diabetes New Zealand booklet, 
Diabetes and healthy food choices,59 a clearly presented and 
easily understood source of dietary information. The 
booklet was used successfully in the LOADD study,60 and 
the PIP pilot study.48
data collection
Data will be collected as part of the intervention appoint-
ments with primary care nurses, as was done in the pilot 
study.48 Study data collection forms have been incorpo-
rated into the Medtech patient management system. 
Additional data will be collected by a research nurse at 
separate study- specific visits. Recruitment began August 
2017, and it is expected that data collection will be 
completed December 2021. The type and frequency of 
measurements are shown in table 1. These include:
Routine clinical data
Clinical data will be collected by primary care nurses. 
These data will include demographics, medical history, 
family history, social history, brief dietary assessment, 
height, weight, waist circumference, blood pressure and 
bloods (HbA1c, total cholesterol, high- density lipopro-
tein cholesterol, triglycerides, liver enzymes (alanine 
aminotransferase, aspartate aminotransferase and 
gamma- glutamyl transferase) and urate. Known data such 
as date of birth and ethnicity will pre- populate the study 
data collection sheets and additional pre- diabetes clinical 
management data (eg, brief dietary assessment details) 
will be added by the primary care nurses during the inter-
vention consultations.
Additional study-specific quantitative data
A research nurse will administer a questionnaire and 
arrange for a fasting blood sample to be taken. The ques-
tions will explore areas known to influence pre- diabetes 
lifestyle management. Data will be collected on self- 
monitoring activities (self- weighing at home, food diaries 
and self- initiated attendance at support groups), social 
support systems,61 62 sleep patterns,63 stages and processes 
in weight management,64 65 physical activity (the Interna-
tional Physical Activity Questionnaire (IPAQ) long)66 and 
HR- QoL using the EQ- 5D.67 68 The additional non- routine 
blood tests will include fasting insulin and fasting glucose 
(to enable calculation of homeostatic model assessment 
(HOMA)69 and the McAuley Index,70 both measures 
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of insulin resistance), and whole genome sequencing 
(WGS) in a sub- sample.
Genetic testing
The genomes from participants who, in addition to the 
main study, provide consent to genetic testing, and are 
from the opposite ends of the response spectrum will be 
sequenced, with the intention of sequencing genomes 
from all consenting participants as the cost of sequencing 
reduces. Using genome- wide single nucleotide poly-
morphism (SNP) genotyping platforms would not be 
adequate as these platforms use common genetic variants 
identified in other populations. WGS is the only practical 
approach as it will allow identification of uncommon 
(including Māori- specific) variants predicted to have a 
strong functional effect in the suite of genes to be analysed 
for a burden of functional variation. WGS also allows eval-
uation of regulatory variants which would not be possible 
using an exome sequencing approach. Sequencing will 
be done at 30- fold coverage.
outcome measures
The primary outcome measures will be HbA1c (mmol/
mol) and weight (kg). Other outcome measures will 
include waist circumference, BMI, social support score, 
behavioural change score and EQ- 5D scores.
sample size calculations
The sample size calculation used information from the 
Voglibose study.21 71 It was assumed that 25% of those with 
pre- diabetes at baseline will regress to normoglycaemia 
at 6 months. Assuming 5% loss to follow- up at 6 months, 
a sample of 400 people with pre- diabetes will provide 
80% power to detect factors associated with regression at 
6 months with relative risks for regression of 2.2 or higher, 
for any two groups each comprising between 20% and 
80% of the sample using a two- sided test at p<0.05 level 
of significance.
Planned statistical analysis
STROBE (Strengthening the Reporting of Observational 
Studies in Epidemiology)72 and TRIPOD (Transparent 
Reporting of a multivariable prediction model for Indi-
vidual Prognosis Or Diagnosis)73 reporting standards 
will be used. Descriptive statistics will be provided for all 
measures of interest, as appropriate. For inferential anal-
yses, all results will be reported showing effect sizes, 95% 
CIs and p values. Two- sided p<0.05 will be considered 
statistically significant. Analyses will be conducted using R 
V.3.5.1 and Stata V.15.1 (or later versions).
Poisson regression with robust standard errors and 
clustered by practice (using Froot’s extension to Huber–
White estimators74) will be used to identify predictors of 
regression to normoglycaemia and progression to T2DM 
at 6 months. Similar models will be used to examine 
risk factors for developing T2DM at 2 years. Exploratory 
modelling will use Markov models to identify variables 
associated with transitions between the three glycaemic 
states of interest, defined according to the NZ definitions: 
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normoglycaemia (HbA1c<41 mmol/mol), pre- diabetes 
(41 mmol/mol≥HbA1 c ≤ 49 mmol/mol) and diabetes 
(HbA1c>49 mmol/mol).52 Providing the number of tran-
sitions between each pair of states is sufficient, multistate 
models will initially be used to describe transition proba-
bilities between these states over all measurement times 
(all three transitions are possible) with an absorbing state 
of death also reachable from any of these three states. 
Factors associated with transitions between these three 
glycaemic states (but not between these states and death) 
are the focus of this study and these prognostic variables 
will be used to construct models of the relative risks for 
transitions between each pair of stages. Initially, these 
factors will be evaluated independently and Hosmer–Le-
meshow’s criteria for logistic regression of unadjusted 
p<0.25 will be used to identify candidate predictors for 
further (adjusted) modelling.75 The number of potential 
predictors included in adjusted models will be limited by 
the number of transitions providing data for parameter 
estimates. Peduzzi et al’s heuristic for logistic regression 
of 10 events (and 10 non- events) per parameter estimated 
will be used to determine the maximum model complexity 
when identifying predictors for further examination.76 If 
more factors are identified than can be modelled using 
the Hosmer- Lemeshow screening heuristic, selection will 
be based on favouring modifiable factors which could 
be used to inform interventions over non- modifiable 
factors. Similarly, where multiple predictors are identified 
that are highly correlated, only one will be retained for 
further modelling. If data allow estimation of the neces-
sary number of parameters, time- dependent transition 
probabilities will be estimated in similar ways.
A genetic risk score will be compiled from common vari-
ants identified as T2DM- associated from a NZ genome- 
wide association study of T2DM currently in progress. 
The genetic risk score will be tested for association with 
the outcomes of the intervention in the sub- sample of 
participants with genetic information.
Qualitative component
Inclusion of qualitative approaches in the design and 
reporting of evaluations of complex health interventions 
is relatively uncommon and rarely reported, although 
qualitative components offer opportunities to enhance 
the interpretation of the quantitative outcome data.77–79 
The qualitative component of this study will provide 
important insight into the psychosociocultural factors 
that influence lifestyle change in relation to regression 
to normoglycaemia. It will specifically explore the expe-
rience of being diagnosed with pre- diabetes and how 
both those who regress to normoglycaemia at 6 months 
and those who do not describe the process in relation to 
barriers to and facilitators of lifestyle changes.
A purposive sample of 60 participants who have 
completed the 6- month intervention will be sought (30 
people who regressed to normoglycaemia and 30 people 
who did not). The sample will be stratified to include equal 
numbers of participants by gender and half of the sample 
will comprise indigenous Māori to ensure that a mean-
ingful level of analysis can be undertaken. Participants 
will be selected from those who agreed to participate in 
further research when first recruited into the main study. 
Those purposively selected will be contacted shortly after 
completion of the 6- month measures to arrange a face- to- 
face interview if willing to participate in this part of the 
study. Written consent will be obtained immediately prior 
to this interview, which will last approximately 60 min. 
The interviewer (SA), who has, with co- author (DT- L), 
worked and published extensively in projects where the 
cross- cultural context is central, will ensure cultural safety 
throughout the interview process with Māori and Pacific 
participants.80 81With permission, all interviews will be 
audio recorded and transcribed.
Analysis will be completed by a sub- team (SA, LW, 
DT- L and KC) using thematic analysis.82 This will involve 
multiple reading of transcriptions followed by the devel-
opment and description of a priori and emergent themes 
and concepts. Further analysis will explore interconnec-
tions between themes. The thematic findings will also be 
triangulated with the quantitative data to assist interpreta-
tion of results and provide descriptive context.83
Economic analysis
Using the EQ- 5D scores, the number and percentage 
of participants reporting each level of problem on each 
dimension of the EQ- 5D will be described by age, gender 
and ethnicity, and compared across time and groups (ie, 
those who regress to normoglycaemia, those who have 
persistent pre- diabetes and those who progress to T2DM). 
Participants’ self- reported health status as measured on 
the EQ Visual Analogue Scale will also be reported. An 
estimate of potential cost savings (acknowledging that 
any change in glycaemic status cannot be attributed to 
the programme with certainty) will be calculated from a 
funder’s perspective using average cost estimates and the 
expected rate of progression to T2DM.
EthICs And dIssEMInAtIon
Local consultation with Māori was facilitated via Health 
Hawke’s Bay’s Operational Māori Advisor and was under-
taken at the outset of study planning, particularly in rela-
tion to the genetic studies. The study was endorsed by the 
Priority Population Committee of the regional primary 
health organisation, Health Hawke’s Bay. This committee 
is tasked with ensuring programmes contribute to equi-
table access and health gains for Māori, Pacific and other 
populations living in high deprivation areas (NZ depri-
vation score 9–10).84 Study author, DT- L (Māori public 
health physician), performed an advisory role across all 
appropriate planning components of the study and will 
be in- field cultural advisor across the project, in particular 
for the research nurse and the qualitative researcher. The 
study was also endorsed by the University of Otago Ngāi 
Tahu Research Consultation Committee.
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Further consultation was undertaken specifically with 
respect to taking blood for genetic analysis. Families will 
be interested in learning if there is a genetic link with a 
higher risk of T2DM. The most obvious outcome would 
include a more responsive health system with early detec-
tion, destigmatisation, early ‘no blame’ intervention and 
prevention programmes for family who are at risk of 
developing T2DM. As part of the study, participants will 
be given a choice on consenting as to the disposal of body 
fluids/parts as per the University of Otago’s and Hawke’s 
Bay District Health Board’s Policies and Procedures.
The main study results will be first presented to partic-
ipating GPs and participating patients. The results of 
the study will be written and published in peer- reviewed 
journals and presented at relevant conferences. A written 
summary of the results will also be distributed to partic-
ipants, participating GPs, and published on Health 
Hawke’s Bay website for their members.
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